| scholarly article | Q13442814 |
| P50 | author | Donald Morton | Q16019759 |
| P2093 | author name string | Atsushi Tanemura | |
| Steven J O'Day | |||
| Dave S B Hoon | |||
| Minoru Kitago | |||
| He-Jing Wang | |||
| Sandy L Nguyen | |||
| Takuji Mori | |||
| Steve R Martinez | |||
| Naoyuki Umetani | |||
| Andy N Tran | |||
| P2860 | cites work | Worms gang up on bacteria | Q27860588 |
| The nuclear receptor superfamily: the second decade | Q27860725 | ||
| Gene silencing in cancer in association with promoter hypermethylation | Q29617274 | ||
| Steroid hormone receptors: many actors in search of a plot | Q29618397 | ||
| Emerging molecular markers of cancer. | Q30330271 | ||
| Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients. | Q33337168 | ||
| Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy. | Q33344271 | ||
| Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy. | Q33796956 | ||
| Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial | Q33796997 | ||
| Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients | Q33797051 | ||
| The loss of estrogen and progesterone receptor gene expression in human breast cancer | Q33923695 | ||
| Estrogen receptors and proliferation markers in primary and recurrent breast cancer | Q33953032 | ||
| Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma | Q34121782 | ||
| Synthesis of universal unmethylated control DNA by nested whole genome amplification with phi29 DNA polymerase. | Q34396042 | ||
| Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Gr | Q34747181 | ||
| Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis | Q35597680 | ||
| Estrogen receptor expression in prostate cancer and premalignant prostatic lesions | Q35787781 | ||
| An evidence-based staging system for cutaneous melanoma | Q35804192 | ||
| Circulating nucleic acids and proteomics of plasma/serum: clinical utility | Q35835700 | ||
| Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers | Q36695878 | ||
| Oestrogen receptors in human malignant melanoma | Q39396630 | ||
| Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients | Q40082103 | ||
| A methylation profile of in vitro immortalized human cell lines. | Q40483038 | ||
| Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer | Q40490715 | ||
| Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation | Q40623346 | ||
| Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients | Q41644933 | ||
| Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence | Q41732822 | ||
| Clinical significance of circulating DNA microsatellite markers in plasma of melanoma patients | Q41736854 | ||
| Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. | Q42596171 | ||
| Age-dependent methylation of ESR1 gene in prostate cancer | Q43741331 | ||
| Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. | Q43755864 | ||
| The effect of tamoxifen on the growth of human malignant melanoma in vitro | Q44001427 | ||
| Estrogen receptor status in malignant melanoma | Q44125160 | ||
| Allelic imbalance on 12q22-23 in serum circulating DNA of melanoma patients predicts disease outcome | Q44829269 | ||
| The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921). | Q49047010 | ||
| Estrogen receptor in malignant melanoma. | Q52591292 | ||
| Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer. | Q53357936 | ||
| A quantitative promoter methylation profile of prostate cancer. | Q53362096 | ||
| Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. | Q54498917 | ||
| The fundamental role of epigenetic events in cancer | Q56421597 | ||
| Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway | Q58329828 | ||
| Tamoxifen as a single agent for advanced melanoma in postmenopausal women. A phase II study of the EORTC Malignant Melanoma Cooperative Group | Q67949609 | ||
| Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen | Q68217218 | ||
| Absence of estrogen receptor in human melanoma as evaluated by a monoclonal antiestrogen receptor antibody | Q68955864 | ||
| Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma | Q73181807 | ||
| Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition | Q73393598 | ||
| A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma | Q77386107 | ||
| Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors | Q77556929 | ||
| Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis | Q81570140 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | estrogen | Q277954 |
| P304 | page(s) | 6692-6698 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Estrogen receptor-alpha methylation predicts melanoma progression | |
| P478 | volume | 66 |
| Q64915632 | A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma. |
| Q92328856 | Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma |
| Q37737945 | Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities. |
| Q35989635 | Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma |
| Q34272080 | Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation. |
| Q34072329 | Association of TNFRSF10D DNA-methylation with the survival of melanoma patients |
| Q54208544 | Association of promoter methylation of ERα and ERβ with sporadic breast cancer--a study from North India. |
| Q36906147 | Augmentation of effects of interferon-stimulated genes by reversal of epigenetic silencing: potential application to melanoma |
| Q35023463 | Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome |
| Q38668171 | Circulating epigenetic biomarkers in melanoma. |
| Q36915595 | Correlations Between Cutaneous Malignant Melanoma and Other Cancers: An Ecological Study in Forty European Countries |
| Q84275444 | CpG island methylator phenotype of multigene in serum of sporadic breast carcinoma |
| Q34431099 | Critical role for lysine 685 in gene expression mediated by transcription factor unphosphorylated STAT3. |
| Q34359695 | DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations |
| Q33372943 | DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage |
| Q33617915 | DNA methylation characteristics of primary melanomas with distinct biological behaviour. |
| Q37280956 | DNA methylation in circulating tumour DNA as a biomarker for cancer |
| Q28087759 | Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer |
| Q36080974 | Epigenetic biomarkers in skin cancer |
| Q36286662 | Epigenetic mechanisms in commonly occurring cancers. |
| Q37531849 | Epigenetics in human melanoma |
| Q38012175 | Epigenetics of estrogen receptor-negative primary breast cancer |
| Q33980682 | Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies |
| Q37380194 | Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. |
| Q38660042 | Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives. |
| Q37690414 | Expression of Estrogen Receptor Alpha in Malignant Melanoma |
| Q37409032 | Genetics and genomics of melanoma |
| Q37045217 | Growth factors and oncogenes as targets in melanoma: lost in translation? |
| Q37667080 | Liquid Biopsies for Assessing Metastatic Melanoma Progression |
| Q47726847 | Liquid biomarkers in melanoma: detection and discovery. |
| Q38700529 | Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients |
| Q36954814 | Melanocyte receptors: clinical implications and therapeutic relevance. |
| Q38347295 | Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome. |
| Q26772077 | Methylated circulating tumor DNA in blood: power in cancer prognosis and response |
| Q35069309 | Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients |
| Q91045454 | Prediction and Analysis of Skin Cancer Progression using Genomics Profiles of Patients |
| Q36905877 | Prognostic molecular biomarkers for cutaneous malignant melanoma |
| Q27001734 | Progression of cutaneous melanoma: implications for treatment |
| Q35998100 | Regulation of STAT signaling by acetylation |
| Q38485889 | Targeting JAK kinase in solid tumors: emerging opportunities and challenges |
| Q37205801 | The impact of genomics in understanding human melanoma progression and metastasis |
| Q37004756 | The role of estrogen receptor in melanoma |
| Q37286893 | Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy |
Search more.